In Brazil, it is estimated that approximately 8.8 million women (about 12.3% of the female population) present symptoms highly suggestive of lipedema, frequently associated with comorbidities like hypertension, anemia, anxiety, and depression.9 Notably, body dissatisfaction and psychological distress have contributed to increased awareness and demand for diagnosis of this condition.3,10 Nevertheless, lipedema continues to be underdiagnosed or misdiagnosed, often confused with conditions such as lymphedema, lipohypertrophy, cellulite (also known as gynoid lipodystrophy), or obesity.10,11 Currently, there is no reliable biomarker or widely accessible diagnostic tool for lipedema
Volume 200
10.1053/j.gastro.2011.07.032 11
The latest report offers answers to some questions but kicks others wide open
Cardiovascular Benefits Some research suggests that semaglutide may have cardiovascular benefits, such as reducing the risk of heart attack or stroke, although further studies are needed to confirm these findings
Once the treatment is stopped, the effects are reversed fairly quickly
